Many Burkitt lymphoma cell lines have mutant p53 [31, 32], so we investigated BCL2 transcript levels and found that MB-3 inhibition downregulated BCL2 expression in Ramos cells (Figure 3E). Here, BCL2 is linked to Burkitt lymphoma.